RecruitingPhase 3NCT05120076

Perioperative Dexamethasone Reduces Postoperative Pain and Nausea After Periacetabular Osteotomy

Perioperative Dexamethasone Reduces Postoperative Pain and Nausea After Periacetabular Osteotomy- a Double-blinded Placebo Controlled RCT

Sponsor

Balgrist University Hospital

Enrollment

60 participants

Start Date

Jul 16, 2021

Study Type

INTERVENTIONAL

Conditions

Pain Postoperative Nausea Amount of Postoperative Opioid Use in Milligrams

Summary

The purpose of this study is to assess the effect of Dexamethasone on postoperative pain and nausea after periacetabular osteotomy.

Eligibility

Min Age: 18 YearsMax Age: 99 Years

Inclusion Criteria5

Age ≥ 18 years
General anasthesia
Elective periacetabular osteotomy for any reason
Written informed consent as documented by signature (Appendix Informed Consent Form)
Competent German language skills

Exclusion Criteria9

Chronic pain patient, chronic lower back pain
Steroid or immunosuppressive drugs used within 6 months of surgery
Renal failure, hepatic failure
Relevant allergies
Pregnancy/ Breast feeding
Contraindications for Fortecortin treatment according to Swissmedic
Previous enrollment into the current study
Participation in another study with investigational drug within the 30 days preceding and during the present study
Known or suspected non-compliance, drug or alcohol abuse Illness according to "Warnings and Precautions of Dexamethasone and NaCl"

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDexamethasone 4 Mg/mL Injectable Solution

s. arm/group description

DRUGNaCl 0.9%

s. arm/group description

Locations(1)

Uniklinik Balgrist

Zurich, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05120076

Related Trials

Anatomical Axis on X-Ray and Its Relationship With Pain and Kinesiophobia in Knee Osteoarthritis

NCT071685901 location